Latest News and Press Releases
Want to stay updated on the latest news?
-
MISSION VIEJO, CA--(Marketwired - Sep 11, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) National Institutes of Health - National Institute of Neurological...
-
MISSION VIEJO, CA--(Marketwired - Aug 14, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and chemical threats with...
-
Aeolus' AEOL 10150 Significantly Improves Survival From Nitrogen Mustard Exposure to Skin in Animals
MISSION VIEJO, CA--(Marketwired - Jul 2, 2013) - Aeolus Pharmaceuticals (OTCQB: AOLS) Data presented at 6th Annual NIH CounterACT Network Research Symposium ...
-
MISSION VIEJO, CA--(Marketwired - Jun 26, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) Data presented at 7th Annual NIH CounterACT Network Research...
-
MISSION VIEJO, CA--(Marketwired - May 17, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...
-
MISSION VIEJO, CA--(Marketwired - May 15, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...
-
MISSION VIEJO, CA--(Marketwire - Mar 14, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) Bill Signed into Law by President Obama Passed Senate...
-
MISSION VIEJO, CA--(Marketwire - Feb 19, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) Beginning Third Year of $118.4 Million BARDA Advance Research and...
-
MISSION VIEJO, CA--(Marketwire - Feb 19, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...
-
MISSION VIEJO, CA--(Marketwire - Jan 2, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...